TSANZ home

Results for "Vape"

Home 5 Search query for: Vape
Results for "Vape"
VOLUME 5.04 – JUNE 2020

VOLUME 5.04 – JUNE 2020

Research Roundup:

June 2020

 

Welcome Message

Welcome to this exciting update of the Research Roundup.

Many of you would have experienced the success of our first virtual Ann Woolcock Award presentation session. I congratulate all the finalists for adapting so well to this new format and to the audience who quickly settled into the Zoom Q&A system and challenged the speakers with stimulating questions.

The RSC members are having a well-earned break from their arduous but rewarding grant review duties, and both I and the Society sincerely thank these members for all their hard work. Their break will be short as awards will open again in the coming months.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the June edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

2020 Respiratory Research Excellence Awards

 

TSANZ congratulates the following award winners!!!

 

Ann Woolcock New Investigator Award Winner: Kurtis Budden

Ann Woolcock New Investigator Award Finalists: Kak-Ming Ling, Rebecca Stockwell, Steven Taylor, Pamela Laird, Razia Zakarya

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship: Simon Craig

TSANZ/AstraZeneca Respiratory Research Mid-Career Fellowship: Hayley Scott

TSANZ/AstraZeneca Respiratory Research Early Career Fellowship: Steven Taylor

Australian Cystic Fibrosis Research Trust 2020 Innovation Grant: Abdullah Tarique, Peter Sly, Emmanuelle Fantino, Clair Wainwright, and Scott Bell

Vertex Adult Cystic Fibrosis Research Award: Sandra Hodge, Peter Zalewski, David Parsons, Andrew Tai, Sally Chapman, Judith Morton, and Emily Hopkins

Vertex Paediatric Cystic Fibrosis Research Award: Shafagh Waters and Adam Jaffe

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease: Mariane T Turner, Samuel Sameh, Robert A Cohen, and Deborah H Yates           

TSANZ Rob Pierce Grant-In-Aid for Indigenous Lung Health: Kristin Carson-Chahhoud

TSANZ Peter Phelan Paediatric Research Award: Shivanthan Shanthikumar

TSANZ / Boehringer Ingelheim Australia COPD Travel Award: Katrina Tonga

TSANZ / Boehringer Ingelheim New Zealand COPD Travel Award: Hajar Ali

TSANZ/JRS Early Career Development Award: Saleela Ruwanpura

Janet Elder International Mid-Career Travel Award: David G Chapman

Janet Elder International Early Career Travel Award Recipient 1: Steven Taylor

Janet Elder International Early Career Travel Award Recipient 2: Tony Zhang

TSANZ Respiratory Nurses Career Development Award for Indigenous Research:Kobi Schutz

 

TSANZ would like to thank our partners and sponsors for their support of excellent respiratory research and researchers!

2020 TSANZ Awards by Nomination

At TSANZ 2020 AGM we recognised seven leaders in their field of lung health.

TSANZ 50th Anniversary Medal for Education and Training – Associate Professor David Fielding.

The 50th Anniversary Medal is awarded each year in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand.

TSANZ Research Medal – Professor Shyamali Dharmage, Professor Alan James

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand. This year, due to the calibre of nominations, the TSANZ Board has chosen two recipients for the TSANZ Research Medal.

TSANZ Society Medal – Associate Professor Tara Mackenzie

This award acknowledges the recipient’s outstanding contribution to the advancement of the practice of thoracic medicine in Australia and New Zealand.

Fellowships

  • Professor Richard Beasley
  • Professor Margaret Wilsher
  • Professor Ross Vlahos

Each year the TSANZ board considers peer nominations for Fellow status of the Thoracic Society of Australia and New Zealand (TSANZ). Fellow status is awarded to members who have demonstrated exceptional contributions to the field of respiratory health in Australia or New Zealand.

Congratulations to all!

Respirology – Editor’s Choice 

Respirology Issue 25.5 May 2020

 

Artificial stone-associated silicosis in China: A prospective comparison with natural stone-associated silicosis

Na Wu, Changjiang Xue, Shiwen Yu and Qiao Ye

 

Chest HRCT of 2 peatients with natural stone-associated findings (top) and 2 patients with artificial stone-associated silicosis (Bottom)

DOI: 10.1111/resp.13744

 

Acute exacerbations of fibrotic interstitial lung diseases

Atsushi Suzuki, Yasuhiro Kondoh, Kevin K. Brown, Takeshi Johkoh, Kensuke Kataoka, Junya Fukuoka, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Jun Fukihara, Masahiko Ando, Tomonori Tanaka, Naozumi Hashimoto, Koji Sakamoto and Yoshinori Hasegawa

 

Researchers from the ILD collaborative team from Japan and US. From left to right: (front) Dr. Yasuhiro Kondoh, Dr. Kevin K. Brown, Dr. Yoshinori Hasegawa; (back) Dr. Atsushi Suzuki, Dr. Koji Sakamoto, Dr. Naozumi Hashimoto, Dr. Kensuke Kataoka, Dr. Yuji Saito.

DOI: 10.1111/resp.13682

Respirology Issue 25.6 June 2020

 

Effects of E-cigarette E-liquid components on bronchial epithelial cells: Demonstration of dysfunctional efferocytosis

Miranda P. Ween, Rhys Hamon, Matthew G, Macowan, Leigh Thredgold, Paul R. Reynolds and Sandra J. Hodge

 

A collection of e-cigarettes and e-liquids for sale to vapers

DOI: 10.1111/resp.13696

 

Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF

Erica Farrand, Eric Vittinghoff, Brett Ley, Atul J. Butte and Harold R. Collard

 

 

The research team from the University of California San Francisco in the United States (c269928 represents Brett Ley)

DOI: 10.1111/resp.13753

TSANZSRS 2020 Abstracts

Due to the COVID-19 pandemic, the TSANZSRS 2020 ASM has been postponed until 30 April – 4 May 2021. This supplement contains Abstracts that were accepted for presentation at the 2020 meeting.

Volume 25, Issue S1 TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, 27–31 March 202

 

Invitations and surveys

 

CYSTIC FIBROSIS RESEARCH AND ADVOCACY PRIORITY SETTING SURVEY 2020 AND BEYOND

Dear Members of the Thoracic Society of Australia and New Zealand,

Cystic Fibrosis Australia (CFA) is inviting the TSANZ members to take part in their Research and Advocacy Priority Setting survey. If you are a CF stakeholder, living with the condition or looking after someone who lives with the condition, then your survey responses are greatly needed and encouraged.

https://www.surveymonkey.com/r/F38Q8K2

We want all our community members, patients, carers, clinicians and researchers to be involved in every step and we thank you for agreeing to take part.

To speak to us about this questionnaire or for any further enquires, contact us at (02) 9889 5171 or email nickim@cfa.org.au. Alternatively, you can join the conversation over at the Cystic Fibrosis Australia page on Facebook.

 

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

NURSES’ ATTITUDES TO CARING FOR PEOPLE WITH INTELLECTUAL DISABILITY: AN AUSTRALIAN SURVEY

Dear Colleagues,

We invite you to consider participating in our online survey focused on nurses’ attitudes to caring for people with intellectual disability. This survey, led by researchers from Western Sydney and Central Queensland Universities, is a replication of a previous US study by Dr Melissa Desroches from the University of Massachusetts, Dartmouth.

People with intellectual disability have lower levels of general health than other members of our community. They also have higher incidence of hospitalisation and, of major concern, higher incidence of preventable death than members of the general population.

By learning about nurses’ attitudes to caring for people with intellectual disability, we anticipate being able to develop models of care and supportive resources for nurses to enhance the care that they provide to people with intellectual disability.

Please read the attached participant information sheet and consider completing this short survey by accessing the link below:

Caring for People with Intellectual Disability survey

Thank you for considering our invitation
A/Prof Nathan Wilson, Western Sydney University
Dr Peter Lewis, Western Sydney University
Ms Virginia Howie, Central Queensland University
Dr Melissa Desroches, University of Massachusetts, Dartmouth

Kind regards,
Virginia

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

 

IDENTIFYING BARRIERS AND FACILITATORS TO THE IMPLEMENTATION OF BEST PRACTICE FOR PULMONARY FIBROSIS IN AUSTRALIA

What are the barriers and facilitators to implementing best practice?

Dear Members of the Thoracic Society of Australia and New Zealand,

The Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is inviting physicians involved in the management of people with pulmonary fibrosis (PF) to take part in our study aimed at identifying the barriers and facilitators to the implementation of best practice for the diagnosis, treatment and management of the disease.

Participation is voluntary and involves providing your views, opinions and experiences on the management of PF through confidential, in person interviews of about 30 minutes in duration. 

Your perspective is important to help us understand the barriers that may be impeding the implementation of best practice in clinical settings. The findings have the potential to guide the development of behaviour change strategies aimed at improving implementation and in turn, optimise the prognosis and management pathways for people with this insidious disease.

Like more information or interested in participating? Click here

The study has been approved by the Monash University Human Ethics Committee (Number 22350) and the Sydney Local Health District Human Ethics Committee (Number 2019/ETH13556).

If you would like to speak to us about any aspect of this study, please contact:

Professor Anne Holland
Professor of Physiotherapy, Monash University and Alfred Health
Department of Allergy, Clinical Immunology and Respiratory Medicine, Monash University
Anne.Holland@monash.edu or (03) 9903 0214

Thank you for your time and consideration of our study.

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

 

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

.

 

VOLUME 5.04 – JUNE 2020

VOLUME 2.7 SEPTEMBER 2017

Research Roundup:

September  2017

.
 

Welcome Message

We are pleased to announce that the TSANZ Awards for Research and Career Development are now open!

The TSANZ awards that you all know well are now open. We would like to highlight two of these awards which have been revised to open up the eligibility and use of these important funds. The TSANZ Peter Phelan Research Award is no longer limited to travel and funding may now be used to support any research venture in paediatric research, including but not limited to; training, travel, equipment, methodology, analysis, technical consult and/or consumables. Furthermore, the Maurice Blackburn Grant-in-Aid for Occupational Lung Disease is no longer bound to asbestos-related research and is open for applications for research into any occupational lung disease. We also have a brand new award – we are excited to offer for the first time the TSANZ/LFA CSL Behring Research Award for Alpha-1 anti-trypsin deficiency

Remember too, abstract-linked awards will close on 13 October as submissions for the TSANZSRS ASM 2018 close. Apply now for some of the many abstract-linked awards and take the opportunity to present your work to our full membership by entering the Ann Woolcock New Investigator competition.

The full list of awards and more information on these can be found in the Open Awards section of this newsletter and on the TSANZ Awards web page.

Like many of our members, we have recently returned from the European Respiratory Society Congress where an overwhelming amount of scientific and clinical advances, discussions and debates were had over five days. The abstracts for most sessions can be found here and the limbic have provided us with some articles below highlighting key messages.

Enjoy the September edition of your research roundup.

Prof Phil Hansbro

Prof Sandra Hodge

Co-Chairs, Research Sub-Committee

The following articles will take you to thelimbic.com

ERS Review

We need to radically rethink asthma

Quadruple ICS a game changer for severe asthma

Revised GOLD criteria under scrutiny

CT scans help guide emphysema treatment

Mixed results for biologic in eosinophilic COPD

Vaping: Smokers also vape, respiratory irritants rife

The Holy Grail

How the heart matters in COPD. In this week’s holy grail Rain Shafuddin from New Zealand tells us how his work is contributing to the changing paradigm of cardiac dysfunction in COPD patients.  Read More.

Top articles from the limbic

Stormy debate over thunderstorm asthma. Clinicians are debating whether to suggest seasonal preventative corticosteroids for people who have mild asthma plus hay fever in new guidelines for thunderstorm asthma prevention in Victoria. Read More.

Oxygen in ILD is complicated. The stigma associated with oxygen use, its complexity of use and an ‘evidence-free zone’ conspire against achieving optimal management of patients with interstitial lung disease. Read More. 

Fan-tastic intervention for chronic breathlessness. Patients with breathlessness are using hand-held fans to delay the use of oxygen therapy and inhaled beta-agonists. Read More.

ICS/LABA combination dominates Australian asthma treatment. Australians using an inhaled corticosteroid for asthma are almost twice as likely as New Zealanders to take it in combination with a long-acting beta agonist but disease control is equally poor in both countries, new research has shown. Read More.

COPD and asthma contribute to global burden of disease.  COPD caused 3.2 million deaths worldwide in 2015 – up almost 12% from 1990 as population growth and ageing outweighed any downward trend in age-standardised death rates. Read More.

Open Awards

Thoracic Society Awards

Abstract-linked awards now open

To apply for an abstract-linked award, you must complete the application coversheet using the upload functionality in the online abstract submission portal

Ann Woolcock New Investigator Award

Boehringer Ingelheim COPD Travel Award

Janet Elder International Travel Award

Japanese Respiratory Society (JRS) Early Career Development

TSANZ Travel Grants to 2018 ASM

For more information visit http://www.tsanzsrs2018.com/abstracts/tsanz-awards-criteria/

Abstracts close 13 October 2017

 

TSANZ Research and Career Development Awards now open

TSANZ Peter Phelan Research Award

TSANZ Indigenous Respiratory Nursing Award

TSANZ / National Asthma Council Australia – Asthma and Airways Fellowship

Boeringher Ingelheim COPD Research Award

Maurice Blackburn Grant-in-Aid for Occupational Lung Disease

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health

TSANZ/LFA CSL Behring Research Award for Alpha-1 anti-trypsin deficiency 

Awards close 13 November 2017

For more information visit https://www.thoracic.org.au/researchawards/tsanz-awards

More opening coming soon!

 

Lung Foundation Australia Awards

Lung Foundation Australia / Cochrane Airways Australia Scholarship 2018

Lung Foundation Australia and Cochrane Airways Australia invite applications for the Lung Foundation Australia/Cochrane Airways Australia Scholarship 2018 valued at $2,500. This scholarship is intended to assist with the completion, update and/or presentation of a Systematic Review. Cochrane Review Scholarships have been awarded on an annual basis since 2001, and have been highly productive.

A Cochrane review is an ideal topic for an advanced trainee in any health profession, or when initiating a PhD program, as most reviews can be completed within a year. Completed reviews are published on the Cochrane Database of Systematic Reviews (Impact Factor 6.124 effective July 2016) and indexed in Medline. Conducting a review provides experience in critical appraisal of the literature, and other aspects of Evidence-Based Medicine.

MORE INFORMATION

Lung Foundation Australia / A Menarini Pty Ltd 2017 Travel Awards deadline extended to midnight 01 October 17

Lung Foundation Australia and A Menarini Australia Pty Ltd are offering two (2) Travel Grants of up to $1,500 for national conferences to key health professionals and researchers in Australia whose work is focused on improving outcomes for patients living with COPD.

The Travel Grants will be allocated across the following conference:

  • APSR – Asian Pacific Society of Respirology Congress, 23 – 26 November 2017, Sydney, Australia. Applications close midnight 01 October 17.

Extra weighting will apply to those who have submitted an accepted Abstract (oral or poster) for the particular conference being applied for. Click here for more information.

Please note: Existing travel payments can be reimbursed for the successful applicants

Apply now

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

TSANZ Awards by Nomination

Nominations for the 2018 year have opened!

The following prestigious awards are presented annually to TSANZ members as an acknowledgment of the recipients’ outstanding and sustained contributions to respiratory health via advocacy and/or clinical practice, research and education. The nomination deadline for all the below awards is midnight AEDT Sunday 15 October 2017. All valid award nominations are submitted to the TSANZ Board for review and selection. 

All of TSANZ’s Awards by Nomination are open to all financial members of the TSANZ. Nominees must be a financial member in the year they are nominated (2017) as well as the year the medal is awarded (2018). All nominations require support from two TSANZ members who are financial in the year the nomination is submitted (2017).

The Society Medal

The Society Medal was conceived as an acknowledgment of excellence in fields other than research, i.e. for the advancement of the practice of thoracic medicine in its widest sense by outstanding teaching or advocacy. Apply Now!

The Research Medal

The Research Medal is awarded in recognition of outstanding contributions to the advancement of knowledge in respiratory medicine or science carried out primarily in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in their field of research. Apply Now!

The 50th Anniversary Medal for Education & Training

The 50th Anniversary Medal for Education & Training was introduced in 2011 to mark the Society’s 50th Anniversary. The 50th Anniversary Medal is awarded in recognition of outstanding contributions to respiratory education and training in Australia or New Zealand. The award recognises an individual who has demonstrated sustained excellence in education and training.

This might take the form of formal and informal teaching within a university, hospital or other health care setting; curriculum development at an undergraduate or postgraduate level; using research to enhance the efficacy of educational activities; career mentoring of junior members of the Society; integration of teaching into clinical practice; or advocacy on behalf of medical education as applied to respiratory medicine. Apply Now!

Members from all disciplines and all branches of the Society are strongly encouraged to nominate a colleague for one of TSANZ’s Awards by Nomination!

Assistance

If you have any queries about submitting a nomination for any of the above awards, please contact the TSANZ office on + 61 2 9222 6200 between 9:00am and 5:00pm AEST or email TSANZoffice@thoracic.org

Fellow of the Thoracic Society

Nominations for the 2018 year have opened!

In 2012 the TSANZ Board created the official honour, Fellow of the Thoracic Society of Australia & New Zealand, to recognise TSANZ members with exceptional expertise and experience in respiratory medicine, research or health service and to acknowledge major contributions to the advancement of respiratory health in Australia or New Zealand.

All valid applications will be submitted to the TSANZ Professional Standards Sub-Committee (PSS) for review, before final ratification by the TSANZ Board.

Criteria

TSANZ Members considering applying for Fellowship of the TSANZ will need to meet the following criteria:

  1. A continuous financial member of TSANZ for five consecutive years in Australia and/or New Zealand as well as a minimum of ten years post-specialist qualification
  2. Contribution to advocacy and/or policy development
  3. Service within the community
  4. Distinguished leadership
  5. Contribution to research
  6. Contribution to teaching or training
  7. International recognition in his or her discipline.

Please Note: Applicants need to demonstrate exceptional contributions to 5 out of the 7 criteria listed above. For the remaining 2 criteria, the applicant must demonstrate a proven track record.

Application

If you would like to submit an application for TSANZ fellowship, or nominate a colleague, please CLICK HERE to download the application form.

Awarding of TSANZ Fellowship

  1. All successful TSANZ Fellow awardees will be announced at the Annual General Meeting at the Adelaide Annual Scientific Meeting in March next year.
  2. Following announcement, successful applicants for TSANZ Fellowship may employ the post nominal FThorSoc whilst remaining a financial member of the TSANZ.
  3. All FThorSoc recipients will receive a certificate, following the AGM.

 

TSANZ Fellows

The following members are recognised as having achieved TSANZ Fellow Status:

2017

  • Abe Rubinfeld
  • David Fielding
  • Hubertus Jersmann
  • Matthew Peters
  • Peter Wark
  • Phil Hansbro
  • Scott Bell
  • Vanessa McDonald

2016

  • Christine McDonald
  • Kwun Fong

2015

  • Adam Jaffe
  • Anne Chang
  • Graham Hall
  • Haydn Walters
  • Ian Yang
  • Jennifer Alison
  • John Upham
  • Peter Gibson
  • Peter Middleton
  • Robyn O’Hehir

2014

  • Anthony Breslin AM
  • Christine Jenkins
  • David Langton
  • David Serisier
  • Gary Anderson
  • Graham Simpson
  • Jo Douglass
  • John Armstrong
  • Martin Phillips
  • Paul Reynolds
  • Peter Frith
  • Peter Sly
  • Peter van Asperen
  • Philip Thompson

2013

  • Robert Edwards

Grant Bulletin

This grant bulletin contains direct-to-researcher grants and awards due between October and December, 2017:

World Cancer Research Fund International – closes 06/10/17
To fund research studies exploring the link between diet, nutrition, body composition, physical activity, and cancer prevention and survival. There are 2 types of grants: Investigator Initiated Grants for Principal Investigators; and Pilot Grants to be used as start-up funds for pilot research. Two main themes: identifying the mechanisms that underpin the effects of diet, nutrition and physical activity on cancer; addressing the host factors that influence an individual’s susceptibility to cancer development or progression.

The Bonser Family Research Grant and Mi-tec Publishing Medical Research Grant – closes 21/10/17
Cancer Council Tasmania calling for research relating to the reduction of the incidence and impact of cancer on individuals and the community. It includes every aspect of care, from prevention and early detection that leads to a better outcome, treatment and supportive care. The priority area is cancer control.

2017 VicHealth Innovation Research Grant – EOI closing date 26/10/17
VicHealth is calling for applications from researchers to undertake a two-year innovative research project that has the potential to generate large health gains for Victorian population groups. Projects must address one of VicHealth’s research priorities: promoting healthy eating; encouraging regular physical activity; preventing tobacco use; preventing harm from alcohol; improving mental wellbeing.

Bill & Melinda Gates Foundation Grand Challenges Explorations Round 20 – closes 08/11/17
Early-stage innovative research projects from a range of disciplines and regions. The challenges for Round 20 are: Healthy Minds for Adolescent Mothers: Achieving Healthy Outcomes for the Family; Innovations for Integrated Diagnostics Systems; Novel Approaches for Improving Timeliness of Routine Immunisation Birthdose and Healthcare Worker Skill in Low-Resource Settings.

Integra Underground Community Investment – closes 01/12/17
Funding is provided for the following focus areas: Capacity Building, including education/training, enterprise development, and economic diversification; Health; Environment.

Pro Bono Australia – Impact 25 Awards (2017) – closes 01/12/17
Award to name the year’s most influential people who have made a significant and positive impact. Nominees should embody the principles of integrity, initiative, foresight, and collaboration.

Australian Respiratory Council Harry Windsor Research Grants Scheme – closes 07/12/17
For projects which address research in tuberculosis, respiratory diseases due to other infections, or respiratory diseases related to tobacco use. Within these categories, projects examining TB/HIV, community issues or the health of disadvantaged groups that relate to the work that the ARC undertakes within Australia and the Pacific Region are particularly encouraged. The proposals can encompass clinical research, public health research or basic scientific research. Grants are available for projects submitted to the National Health and Medical Research Council (NHMRC) which are considered fundable but which do not reach the cut-off mark for funding in any one year.

Perpetual Trustees 2018 IMPACT Philanthropy Application Program – closes 08/12/17
Perpetual distributes to all sectors including social welfare, health, medical research, conservation and environment, education, and arts and culture. As is consistent with Perpetual’s IMPACT Philanthropy Application Program process, an organisation’s submission will be assessed against Leadership, Capability, Strategy and Outcomes. Further 2018 information will be released later in 2017.

Allen Foundation Grants (2018) – closes 31/12/17
Priorities are: to fund relevant nutritional research; to support programs for the education and training of mothers during pregnancy and after the birth of their children; to assist in the training of persons to work as educators and demonstrators of good nutritional practices; to encourage the dissemination of information regarding healthful nutritional practices and habits; in limited situations to make grants to help solve immediate emergency hunger and malnutrition problems.

Rolling Grants

Auswide Community Grants Scheme –  grants under $5 000 close 30/09/17, grants over $10 000 close 21/10/17, grants over$ 5 000 close 01/12/17.
Supports local activities, organisations, events and projects covering a wide range of sporting, cultural and community interests and endeavours. Includes community services, events and celebrations, buildings, public spaces and facilities, research, and organisational development.

John Templeton Foundation
Interest areas are: science and the big questions; character virtue development; freedom and free enterprise; exceptional cognitive talent and genius; genetics; voluntary family planning.

Boehringer Ingelheim Fonds Travel Grants
Grants for non-European researchers to travel to Europe for up to three months to pursue an experimental project in basic biomedical research.

Baxalta Bioscience Grants – Medical Education & Fellowship Grants
Baxalta provides Medical Education & Fellowship Grants to support accredited or unaccredited educational symposia, seminars, web-based sessions, or fellowship programs directed at certified healthcare professionals. They are currently interested in supporting the following areas: Immunology; Hematology; Oncology.

Coopers Brewery Foundation – current round closes 01/08/2017
Medical research and health care; educational development for the young; aged care; promotion of family and community support based on Christian values.

The Balnaves Foundation
The Balnaves Foundation supports organisations that aim to create a better Australia through education, medicine and the arts with a focus on young people, the disadvantaged, and Indigenous communities.

allport bequest – closes 30/06 and 31/12 yearly
Must benefit citizens of Hobart. Organisation must be charitable or the project must be for charitable purposes.

Respirology

Congratulations and thank you to our members involved in the publication of the new TSANZ/LFA IPF position papers. 

Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Helen E. Jo, Lauren K. Troy, Gregory Keir, Daniel C. Chambers, Anne Holland, Nicole Goh, Margaret Wilsher, Sally de Boer, Yuben Moodley, Christopher Grainge, Helen Whitford, Sally Chapman, Paul N. Reynolds, Ian Glaspole, David Beatson, Leonie Jones, Peter Hopkins, Tamera J. Corte

DOI: 10.1111/resp.13146

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Jyotika D. Prasad, Annabelle Mahar, Jane Bleasel, Samantha J. Ellis, Daniel C. Chambers, Fiona Lake, Peter M.A. Hopkins, Tamera J. Corte, Heather Allan, Ian N. Glaspole

DOI: 10.1111/resp.13163

 

Editor’s Choice – Respirology Issue 22.7

Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis

Francesco Bonella, Xiaoping Long, Xuan He, Shinichiro Ohshimo, Matthias Griese, Josune Guzman and Ulrich Costabel

DOI: 10.1111/resp.13082

 

Research team members from Germany and Japan. From left to right: Francesco Bonella, Ulrich Costabel and Shinichiro Ohshimo

 

Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort

Matthew R. Lammi, Lesley A. Saketkoo, Jessica K. Gordon, Paula Lauto, Karen Fagan, Virginia D. Steen and on behalf of the PHAROS Investigators

DOI: 10.1111/resp.13067

 

‘River Spirit’ by glass artist Ray King, displayed in the lobby of University Medical Center New Orleans

 

APSR Fukuchi Award for Best Original Research Paper published in Respirology

Randomized controlled trial of the effect of regular paracetamol on influenza infection
Sarah Jefferies, Irene Braithwaite, Steven Walker, Mark Weatherall, Lance Jennings, Michelle Luck, Kevin Barrett, Robert Siebers, Timothy Blackmore, Richard Beasley, Kyle Perrin, On behalf of the Pi Study Group

DOI: 10.1111/resp.12685

The paper was shortlisted, from all 2016 Respirology research papers, by an international expert panel comprising of Prof Antonio Anzueto (University of Texas, San Antonio, USA), Prof John Mastronarde (Ohio State University, Columbus, USA), Prof Chunxue Bai (APSR Research Committee, Shanghai, China), Prof Albert Li (Prince of Wales Hospital, Hong Kong) and Prof Christina Spengler (ETH Zurich, Switzerland), chaired by Prof Michael Niederman (Weill Cornell Medical College, NY, USA).The award will be formally presented at the next APSR Congress in Sydney, Australia in November 2017.

Research Project and Survey Requests

Current Opinions of Severe Asthma Specialists on the Utility of Biomarkers for the Management of Corticosteroid Treatment: A Survey

If you are an Australian clinician involved in the care of patients with severe asthma, we would be very grateful if you could complete a brief questionnaire.

We would ideally like to sample opinions from specialists involved in the care and management of patients with severe asthma. This is the first round of a multi-national Delphi process to reach a consensus and there will be follow-up questions based on the answers we receive from round one (with likely three rounds in total).

A strategy to optimize corticosteroid use in the severe asthma population using biomarkers is currently being investigated. Professors Peter Wark and Jodie Simpson at the University of Newcastle, Australia are looking at an algorithm to adjust corticosteroid dose using exhaled nitric oxide (FeNO), and peripheral blood eosinophils. This survey is being conducted by them, and will also be part of a Research Masters degree by Dr. James Michael Ramsahai. As part of this project, we would like to seek your views on some aspects of biomarker based corticosteroid adjustment in severe asthma.

For more details, please see the attached information statement. Please note that completion of the survey will imply consent to participate, and for the data collected to be used for analysis. You may withdraw at any time.

If you agree to participate, please follow the link to complete the survey

http://selectsurvey.hnehealth.nsw.gov.au/TakeSurvey.aspx?SurveyID=l6M2m5m3

Thank you,

Peter Wark
Jodie Simpson
J. Michael Ramsahai 
JamesMichael.Ramsahai@uon.edu.au

 

Case Management of Venous thromboembolism

Many thanks for your time in completing this short survey, which should take no longer than 5 minutes. At St. John of God, we are exploring the management of VTE in patients with or without malignancy and in the perioperative setting.

We appreciate there are a large number of guidelines, many of which can be contradictory in their recommendation. Irrespective of this, we would greatly value your feedback on how you would manage the following cases, recognising that several answers may be appropriate.

This survey consists of 4 short cases which will cover a range of clinical scenarios with regards the management of VTE in the immediate post-operative and preoperative period, as well as the management of VTE in the setting of suspected and confirmed solid organ malignancy.

https://www.surveymonkey.com/r/IVCFilter

All results are completely anonymised and your participation is greatly appreciated.

Kind regards,

Prof Eli Gabbay egabbay@respiratorywest.com.au
Dr Philip Craven

 

Australian Society for Medical Research National Scientific Conference

Held in Sydney, at the Charles Perkins Centre, from November 14th to 15th, 2017 the NSC has an exciting new design all packed up in a shorter format.

In these highly competitive times, the NSC 2017 will fulfil an important yet unmet need for early to mid career health and medical researchers.

Entitled “Science and Survival – equipping you with the tools to further your research career” the aims of the  conference are:

  • To empower and inspire our present and future scientific leaders.
  • To provide a springboard for early to mid-career researchers to showcase their research.
  • To promote scientific excellence, collaboration and transdisciplinary research.
  • To upskill in grantsmanship and understand the promotion process.
How are we going to achieve this?

We are very excited about the new format of NSC 2017 with both scientific presentations and visionary professional development workshops.

Conference highlights

Mock GRP session with all the elements of a GRP and the perspective of a narrator.

Inside the scientist studio – Norman Swan  interviews Nobel Prize Winner Professor Peter Doherty.

Politics of promotion to provide invaluable insights into the intricate and necessary journey to Associate Professorship.

The Edwards Orator is Distinguished Professor Jagadish Chennupati from ANU. A stellar transdisciplinary researcher and a nanotechnology pioneer. ­­­He is also a charismatic leader and mentor who will inspire our participants.

Dr Bon-Kyoung Koo from the University of Cambridge will deliver the Firkin Oration. Dr Koo is an ascending star in stem cell research and a world leading researcher in the experimental dissection of human stomach development –  all generated from stem cells.

ASMR Peter Doherty Leading Lights Award.  This year ASMR will launch a new award aimed at recognising the outstanding contributions of Australian mid-career researchers.

The Networking and Mentoring Breakfast.  A unique opportunity for students in particular to share their concerns and ask questions of experienced mentors.

 

 

 

 
 
 
 
 
 
 
 
 

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X